search icon
  • Print
  • ShareThis
  • Text Size

IDSA News Releases

08/24/2015

HCV Guidance Website Adds Section on Cost Effectiveness

HCV has updated several sections of the website based on newly available therapies and data.
07/30/2015

Vertebral Osteomyelitis Must be Diagnosed and Treated Correctly to Prevent Serious Problems

PERSISTENT SEVERE BACK PAIN COULD SIGNIFY RARE SPINE INFECTION: NEW IDSA GUIDELINE
07/30/2015

Infectious Diseases Society of America Honors 113 Distinguished Physicians, Scientists

IDSA is pleased to announce the 2015 FIDSA awardees. Fellowship in IDSA honors those who have achieved professional excellence and provided significant service to the profession.
07/16/2015

IDSA Supports Proposed Stewardship Requirement for Long Term Care, Touts ID Physician Leadership

IDSA has long led advocacy for policies to improve patient care and combat the public health crisis of antibiotic resistance through the use of stewardship programs. Nationwide, infectious diseases (ID) physicians are serving as leaders of stewardship programs in their institutions and communities and will remain essential to lead implementation of this proposed policy.
06/04/2015

White House Antibiotic Stewardship Forum

At this week’s White House Forum on Stewardship, IDSA President Steve Calderwood, MD, FIDSA said, “Our expertise on diagnosing and treating patients with serious infectious diseases makes us particularly well suited to lead multi-disciplinary institution-level stewardship programs that will improve patient outcomes.”
03/27/2015

IDSA: National Action Plan for Combating Antibiotic Resistant Bacteria (CARB) - a Welcome Effort in Tackling Resistance Public Health Crisis

The Infectious Diseases Society of America (IDSA) welcomes the release of the National Action Plan for Combating Antibiotic Resistant Bacteria (CARB).
03/10/2015

Hepatitis C Guidance Website to Develop Section on Cost-Effectiveness of Treatment

An upcoming section on hcvguidelines.org, a website developed by IDSA and AASLD in collaboration with IAS-USA will examine the cost-effectiveness of HCV treatment to help clinicians advise and educate their patients, which is the purpose of the guidance. The new section will not, however, make recommendations regarding the pricing of these therapies for the treatment of HCV.
02/23/2015

You Probably Don’t Need These Five Tests or Treatments, Say Infectious Disease Experts

The Infectious Diseases Society of America (IDSA), in partnership with the ABIM Foundation’s Choosing Wisely campaign, has released a list of five tests or treatments that physicians and patients should question.
02/10/2015

Infectious Diseases Experts Stress Effectiveness and Safety of Vaccination During Measles Outbreak

We urge parents to ensure that their children are up to date with all recommended immunizations, including with the MMR vaccine, to prevent this devastating disease from causing severe disability and death.
02/02/2015

IDSA Applauds Focus on Antibiotic Resistance in President’s FY 2016 Budget Request

IDSA strongly supports the proposal in the President’s Budget Request for Fiscal Year 2016.
//

The Infectious Diseases Society of America (IDSA) welcomes the release of the National Action Plan for Combating Antibiotic Resistant Bacteria (CARB).
//

IDSA has long led advocacy for policies to improve patient care and combat the public health crisis of antibiotic resistance through the use of stewardship programs. Nationwide, infectious diseases (ID) physicians are serving as leaders of stewardship programs in their institutions and communities and will remain essential to lead implementation of this proposed policy.
//

idsa news release
//

IDSA is pleased to announce the 2015 FIDSA awardees. Fellowship in IDSA honors those who have achieved professional excellence and provided significant service to the profession.
//

HCV has updated several sections of the website based on newly available therapies and data.

| HIVMA | Contact Us

© Copyright IDSA 2015 Infectious Diseases Society of America

Full Site Mobile Site